The acceptance and kinetic resolution of alpha-Methyl Substituted Aldehydes by Norcoclaurine Synthase by Roddan, Rebecca et al.
BIROn - Birkbeck Institutional Research Online
Roddan, Rebecca and Gygli, G. and Sula, Altin and Méndez-Sánchez, D.
and Pleiss, J. and Ward, J.M. and Keep, Nicholas H. and Hailes, H.C. (2019)
The acceptance and kinetic resolution of alpha-Methyl Substituted Aldehydes
by Norcoclaurine Synthase. ACS Catalysis , ISSN 2155-5435. (In Press)
Downloaded from: https://eprints.bbk.ac.uk/id/eprint/28917/
Usage Guidelines:
Please refer to usage guidelines at https://eprints.bbk.ac.uk/policies.html or alternatively
contact lib-eprints@bbk.ac.uk.
 1 
The Acceptance and Kinetic Resolution of alpha-
Methyl Substituted Aldehydes by Norcoclaurine 
Synthases 
Rebecca Roddan1,2, Gudrun Gygli3, Altin Sula2, Daniel Méndez-Sánchez1, Jürgen Pleiss3, 
John M. Ward4, Nicholas H. Keep2 and Helen C. Hailes*1 
1Department of Chemistry, University College London, 20 Gordon Street, London, WC1H 
0AJ, UK. 
2Institute for Structural and Molecular Biology, Department of Biological Sciences, 
Birkbeck, University of London, Malet Street, London, WC1E 8HX, UK.  
3Institute of Biochemistry and Technical Biochemistry, University of Stuttgart, Stuttgart, 
70569, Germany 
4Department of Biochemical Engineering, University College London, Gower Street, 
London, WC1E 6BT, UK.  
Corresponding author: Helen C. Hailes (h.c.hailes@ucl.ac.uk) 
ABSTRACT: Norcoclaurine synthase (NCS) catalyzes a stereoselective Pictet-Spengler 
reaction to give the key intermediate, (S)-norcoclaurine in benzylisoquinoline alkaloid (BIA) 
biosynthesis. This family of alkaloids contains many bioactive molecules including morphine 
and berberine. Recently, NCS has been demonstrated to accept a variety of aldehydes and some 
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ketones as substrates, leading to a range of chiral tetrahydroisoquinoline (THIQ) products. 
Here, we report the unusual acceptance of a-substituted aldehydes, in particular a-methyl 
substituted aldehydes, by wild-type Thalictrum flavum NCS (𝛥33TfNCS) to give THIQ 
products. Moreover, the kinetic resolution of several a-substituted aldehydes to give THIQs 
with two defined chiral centers in a single step with high conversions was achieved. Several 
dopamine analogues were also accepted as substrates and reactions were amenable to scale-up. 
Active site mutants of TfNCS were then used which demonstrated the potential to enhance the 
stereoselectivities in the reaction and improve yields. Rationale for the acceptance of these 
substrates and improved activity with different mutants has been gained from a co-crystallized 
structure of 𝛥33TfNCS with a non-productive mimic of a reaction intermediate bound in the 
active site. Finally, molecular dynamics simulations were performed to study the binding of 
dopamine and an a-substituted aldehyde and provided further insight into the reaction with 
these substrates. 
KEYWORDS: biocatalysis, norcoclaurine synthase, tetrahydroisoquinoline, Pictet-Spengler, 
kinetic resolution.  
 
INTRODUCTION: 
Biocatalysis continues to be viewed as a highly valuable synthetic method with several 
advantages compared to traditional organic synthetic approaches due to the non-hazardous 
reagents, ambient reaction conditions, fewer toxic by-products and higher reaction 
stereoselectivities. Methods such as enzyme immobilisation, novel screening methods and 
enzyme mutagenesis are starting to overcome many of the limitations of biocatalysis such as 
their poor stability, low efficiency and narrow substrate scope. Enzymes are therefore 
becoming a more viable, sustainable option for small molecule syntheses.1 
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The in planta role of norcoclaurine synthase (NCS) is the Pictet-Spengler reaction between 
dopamine 1 and 4-hydroxyphenylacetaldehyde (4-HPAA) to give (S)-norcoclaurine as a single 
enantiomer. Norcoclaurine is the first committed intermediate to the benzylisoquinoline 
alkaloid (BIA) family of natural products, so the enzyme is present in many BIA-producing 
plants. NCS isolated from the common meadow rue, Thalictrum flavum (TfNCS), is one of the 
most studied Pictet-Spenglerases.2–5 Indeed, the X-ray crystallographic structure has been 
reported together with mechanistic insights, as well as NMR studies6, and recently and it has 
been established to have good substrate scope.7–9 Notably, NCSs have been shown to accept a 
variety of aldehydes and ketones in place of 4-HPAA to yield different C-1 substituted 
tetrahydroisoquinolines (THIQs) in high stereoselectivities as the (S)-isomer. Very recently, 
density functional theory calculations have also been performed to rationalize the 
stereoselectivity in the NCS reaction to give (S)-norcoclaurine.10 
The THIQ moiety is present in many biologically active molecules which have been shown 
to exhibit a variety of beneficial therapeutic activities including antibacterial11, antitumour12, 
anticoagulant13 and muscle relaxant properties.14,15,16 The THIQ scaffold is therefore a common 
target in drug discovery and thus there is a strong interest in synthesising diverse analogues 
and single isomer products. Accessing single enantiomer THIQ products is challenging using 
traditional organic synthetic methods and often requires the use of expensive and toxic chiral 
catalysts, multistep procedures and often poor enantiomeric excesses have been reported.17,18 
NCS is proving to be a valuable biocatalytic enzyme and has already been employed in the 
stereoselective syntheses of THIQs such as trolline, 1,1’- disubstituted THIQs and spiro-
THIQs.19–23  
NCS has however been reported to show poor tolerance towards a-substituted aldehydes. 
Previously, when Ruff et al. explored the use of D29TfNCS with 2-(1-napthyl)propanal and 
cyclic carboxaldehydes with dopamine, no Pictet-Spenglerase products were detected, which 
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was rationalised as being due to a lack of conformational space in the active site (Scheme 1).8,20 
The acceptance of 1-naphthalene acetaldehyde but not 2-(1-napthyl)propanal also led to the 
rationale that more generally 𝛼-substituted aldehydes were not well tolerated by NCS. 
Interestingly, Nishihachijo et al. and Pesnot et al. reported very low levels of dopamine 
consumption when using 𝛼-methyl substituted aldehydes isobutanal and 2-phenylpropanal 
with Coptis japonica NCS (CjNCS2), indicative that an NCS catalysed reaction may have 
occurred but no products were isolated or characterised.19,21 
 
Scheme 1: NCS a-substituted aldehyde substrate scope demonstrated in previous work and 
in this work.  
 
Incorporating a-methyl aldehydes into THIQs is challenging using traditional organic 
synthetic methods as potentially four different isomers can be formed, unless a single 
enantiomeric aldehyde is used, which would generate two diastereoisomers. Many single-
isomer 𝛼-methyl substituted aldehydes are not commercially available and have been accessed 
via another available chiral molecule or synthesised using chiral auxiliary methods24,25 and via 
asymmetric hydroformylation26. However, these methods are step-intensive, often involve the 
use of toxic reagents and gaining a high enantiomeric excess (e.e.) in the product is challenging. 
The resulting aldehyde products can also be volatile and prone to oxidation and racemisation.27 
































yields up to 97%
1
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routes is non-trivial and can lead to poor enantiopurity in the product. Accessing the resulting 
THIQs from reactions between a dopamine analogue and an 𝛼-methyl aldehyde is 
pharmaceutically relevant. Products have been reported to possess bronchodilatory activities 
and a corresponding isoquinoline has also been shown to have antimalarial activities.28,29 
Corydaline, a 13-methyltetrahydroprotoberberine alkaloid is also a major constituent of 
Corydalis tuber which is in clinical trials in Korea for the treatment of functional dyspepsia.30  
Here, we report the acceptance of several a-substituted aldehydes by wild-type Thalictrum 
flavum NCS (D33TfNCS) to give THIQ products in high yields. In addition, the kinetic 
resolution of 𝛼-methyl substituted aldehydes by NCS, has been achieved resulting in the 
formation of THIQ products with two defined stereocentres. The potential for enzyme 
engineering has also been explored through observing the reactions of a variety of NCS active 
site mutants, resulting in enhanced diastereoisomeric ratios and increased conversions. A co-
crystallised structure of TfNCS with a non-productive reaction intermediate analogue provided 
structural insights into the acceptance of these substrates. Molecular dynamics simulations of 
enzyme-substrate complexes were also performed to model the binding of dopamine and an 𝛼-
substituted aldehyde, the (R)- and (S)-enantiomers of 2-phenylpropanal, to explore the 
molecular basis of stereoselectivity. 
RESULTS AND DISCUSSION: 
Initial NCS Reactions. Following the reported acceptance of ketones as substrates,21 with a 
view to significantly extending the scope of the Pictet-Spenglerase NCS with more sterically 
challenging aldehydes a range of 𝛼-methyl and a-ethyl substituted aldehydes were initially 
tested as substrates. Reactions were investigated using wild-type NCS (WT-D33TfNCS) and 
dopamine 1 with aldehydes 2a-7a (Scheme 2). Remarkably, in all cases, reactions were 
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observed. Notably, the 𝛼-methyl substituted aldehydes 2a-5a were readily accepted by TfNCS 
to give products 2b-5b in high HPLC yields (87-97%). Aldehyde 6a was less readily accepted 
likely due to less rotational freedom of the alkyl chain in the active site and reduced reactivity 
of the conjugated aldehyde.  THIQ 7b was formed in a lower yield most likely due to steric 
reasons. Stereoselectivities are discussed below. Analogous reactions to the higher yielding 
enzyme reactions were also performed without enzyme using potassium phosphate (KPi) and 
acetonitrile (1:1) to give the racemic products 2b-5b in 44-82% yield with no or traces of the 
ortho-product formed, reflecting the more sterically demanding nature of the a-substituted 
aldehydes.31 Racemic products were generated using KPi for use as standards in chiral HPLC 
analyses. In all cases, reaction yields were lower in reactions using KPi as a catalyst (no NCS 
present) compared to with NCS, highlighting the synthetic value of the NCS-mediated 
reactions.  
 
Scheme 2: TfNCS reactions with 1 and the a-methyl and a-ethyl substituted aldehydes 2a-7a. 
Reaction conditions with NCS: dopamine.HCl (10 mM), aldehyde (20 mM), sodium ascorbate 
(5 mM), D33TfNCS (0.2 mg mL-1) in HEPES buffer (100 mM, pH 7.5) with DMSO (10% v/v) 
at 37 oC, 250 µL scale reactions. Reaction conditions with KPi: dopamine.HCl (10 mM), 






























KPi (rac)-2b  56%
 (1S,1’R)-3b  92%
d.r.  94:6
KPi (1RS,1’RS)-3b 44%
























with acetonitrile (50% v/v) at 60 oC. Yields were determined by monitoring product formation 
against standards (by HPLC) unless otherwise indicated; Diastereoisomeric ratios (d.r.s) for 
stereoselective reactions were determined by 1H-NMR spectroscopy; aThe conversion was 
determined by monitoring dopamine consumption (HPLC, SI Section 9.2). 
 
To extend the range of accessible THIQ products using a-methyl substituted aldehydes other 
amine analogues were used. Reactions were also observed with meta-tyramine 8, 
norepinephrine 9 and metaraminol 10. Conversions (based on amine consumption are given in 
Table 1) with aldehydes 2a-5a were lower than those with dopamine and so product formation 
was confirmed by LC-MS. The lower conversions are most likely due to the different binding 
modes of the unnatural dopamine substrates into the active site leading to a decreased 
acceptance of the more challenging aldehyde substrates. However, it highlights the more 
general applicability of using a-methyl substituted aldehydes as NCS substrates.  
 




2a 3a 4a 5a 6a 7a 
 
8 
34% 48% 45% 69% 25% 26% 
 
9 
✔ 65% 57% 79% x x 
 
10 
64% 50% 42% 69% x x 
Reaction conditions: amine (10 mM), aldehyde (20 mM), sodium ascorbate (5 mM), 
D33TfNCS (0.2 mg mL-1) in HEPES buffer (100 mM, pH 7.5) with DMSO (10% v/v) at 37 oC 
for 18 h, 250 µL scale reactions. ✔= product observed but no conversion determined.	x = no 
conversion observed (i.e. no product observed). Reactions were performed in triplicate and 
were consistent within 10% error. Conversions were determined based on amine consumption 












Reaction Stereoselectivity. For reactions with the a-methylated aldehydes, stereoselectivities 
were explored for the highest yielding reactions with dopamine 1. Aldehyde 2a is achiral: chiral 
HPLC analysis of 2b indicated it was formed in >95% e.e., by comparison to the racemic 
standard prepared using the KPi-mediated reaction (Scheme 2), and following previous reports 
using TfNCS this was assigned as the (S)-isomer.19,32 THIQs 3b-5b possess two chiral centres, 
and analysis of the 1H NMR spectra revealed two proton environments for 1-H (ca. 4-5 ppm), 
indicating that two diastereoisomers were present. Since WT-TfNCS typically generates (S)-
THIQs at C-1, it was rationalised that the stereoselectivity at this position was retained and that 
a kinetic resolution of the aldehyde had occurred. Diastereoisomeric ratios (d.r.s) were 
determined by 1H NMR spectroscopy, and high d.r.s were noted for 3b and 5b (94:6). To 
determine which aldehyde was preferentially accepted, (2R)-3a and (2S)-3a were synthesised. 
Aldehyde 5a was not prepared due to the fast racemisation rates reported at pH 7.5.33 Aldehyde 
(2S)-3a was synthesised from the corresponding alcohol (commercially available in 95% e.e.). 
The (2R)-isomer was prepared using an Evan’s chiral auxiliary, subsequent reduction to 
remove the auxiliary and oxidation to give (2R)-3a (Scheme S1). For both isomers, after Swern 
oxidations the aldehydes were not purified by distillation or chromatographic methods to 
minimise the risk of racemisation: 1H NMR spectroscopic data indicated reasonable levels of 
purity for both aldehydes, and chiral GC analysis (Figure S9) indicated (2R)-3a was formed in 
79% e.e. and (2S)-3a in 68% e.e.   
TfNCS reactions were performed with both (2R)-3a and also (2S)-3a; yields were lower than 
previously, most likely due to aldehyde impurities present (see above). HPLC analysis (Scheme 
3a) of the reactions under the same conditions indicated that (2R)-3a was accepted 
preferentially to the (2S)-isomer, confirming that a kinetic resolution was occurring when using 
the racemate. Indeed, the low levels of product formation with (2S)-3a (68% e.e.) most likely 
arose from the small amount of (2R)-isomer present (~16%). Following the established 
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selectivity at C-1 for TfNCS and the NMR spectroscopic data, it was concluded that the major 
isomer formed when using racemic 3a was (1S,1'R)-3b (d.r. 94:6). It was also rationalised that 
the same stereoselectivity arises when using 4a to give (1S,1'R)-4b (d.r. 82:18) as the major 
isomer out of the 4 possible isomers.  
 
Scheme 3: a) Analytical HPLC analysis (SI Section 9.2) of enzymatic reactions between 1 
and isomers (2R)-3a and (2S)-3b. Reaction conditions: dopamine.HCl (10 mM), (R)-3a (30 
mM) or (S)-3a (30 mM) sodium ascorbate (5 mM), purified D33TfNCS (0.2 mg mL-1) in 
HEPES buffer (100 mM, pH 7.5) with DMSO (10% v/v). The total reaction volume was 250 
µL and they were performed at 37 oC with results confirmed in triplicate. b) Analytical HPLC 
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analysis of enzymatic and KPi reactions between 1 and 5a. Reaction conditions for enzymatic 
reaction: dopamine.HCl (10 mM), 5a (20 mM), sodium ascorbate (5 mM), purified D33TfNCS 
(0.2 mg mL-1) in HEPES buffer (100 mM, pH 7.5) with DMSO (10% v/v) at 37 oC for 18 h, 
250 µL reaction volume. Reaction conditions for KPi reaction: dopamine.HCl (10 mM), 5a 
(20 mM), sodium ascorbate (20 mM) in KPi buffer (0.3 M, pH 6) with acetonitrile (50% v/v) 
at 60 oC for 18 h, 1 mL reaction volume.  
 
HPLC analysis of 5b generated using the non-stereoselective KPi-mediated Pictet-Spengler 
reaction31, revealed two product peaks corresponding to 4-isomers (2 sets of diastereoisomers) 
in a ratio of 1:1 (Scheme 3b). 1H NMR spectroscopy confirmed that only a trace of the ortho-
product was formed. When compared to HPLC data for the enzymatic reaction, it was evident 
that an excess of one diastereoisomer was formed (ratio ~95:5) (Scheme 3b) in the enzymatic 
reaction which was consistent with the 1H NMR data. Since arylacetaldehydes react with 
TfNCS to give the (S)-isomer at C-1 in high e.e.s,19 and following the enantioselectivity data 
for 3a, this highlighted that the major product was likely to be (1S,1'R)-5b (d.r. 94:6). Clearly, 
the enzymatic reaction with WT-TfNCS is an excellent route to such THIAs, as the reactions 
give higher yield than the KPi reaction and there is potentially stereochemical control at both 
chiral centres.  
To determine whether the reaction could be readily scaled up, a 0.5 g scale reaction was 
performed using clarified cell lysate of D33TfNCS with 1 and 3a as the aldehyde substrate. The 
product was isolated via an extractive workup and the reaction went to 96% yield (HPLC yield, 
SI Section 9.2) and an isolated yield of 88% was achieved, consistent with the smaller scale 
reactions (92% HPLC yield). 1H-NMR spectroscopic analysis of the product 3b determined 
that the stereoselectivity of the reaction was mostly retained with a d.r. of 87:13 (small scale 
d.r. 94:6). The reduction in diastereoisomeric ratio is most likely due to a small amount of 




Reactions with enzyme variants. To investigate the effect of NCS variants on the 
acceptance of a-methyl aldehydes and products formed, several 𝛥29TfNCS mutants were used 
as enzyme lysates, namely L76V, A79I, A79F, F80L, M97V, M97L, M97V and Y108F with 
1 and 2a, 3a, and 5a. Enzyme variants were chosen based upon docking experiments and 
previous mutagenesis studies to increase the space in the active site for bulkier substrates.8,22 
First, WT-𝛥29TfNCS was used in the reaction and no difference in reactivities or the products 
formed was found compared to with 𝛥33TfNCS. For all three aldehydes, the mutant A79I 
showed higher product yields by HPLC compared to WT and the other NCS variants (Figure 
1), a characteristic that has also been observed with ketones but to a greater extent.22 This 
mutation has been rationalised to increase conversions of hydrophobic substrates due to 
enhanced hydrophobicity in the active site resulting in increased substrate affinity. For the two 
chiral aldehydes 3a and 5a, M97V showed increased yields compared to the wild-type NCS. 
M97 mutants have been used with ketone substrates where decreased yields were noted with a 
reduction in steric bulk at this position i.e. poorer conversions with M97V compared with the 
wild-type.22 Interestingly, the opposite trend was observed here with aldehydes 2a and 5a as 
substrates. 
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Figure 1: Yields of TfNCS reactions with 1 and 2a (a), 3a (b) or 5a (c) to give products 2b, 
3b and 5b respectively. Reaction conditions: Dopamine.HCl (10 mM), aldehyde (20 mM), 
sodium ascorbate (5 mM), D29TfNCS lysate of variant (25% v/v) in HEPES buffer (100 mM, 
pH 7.5) with DMSO (10% v/v) at 37 oC for 18 h, 200 µL scale reactions; Yields were 
determined by monitoring product formation against standards by HPLC (SI Section 9.2). 
Diastereoisomeric ratios of the major (1S,1’R) product to the minor (1S,1’S) product for each 
reaction product of 5b are; WT, 90:10; L76V, 97:3; A79I, 89:11; A79F, 89:11; F80L, 95:5; 
M97V, 97:3; M97L 91:9; M97F, 92:8; Y108F, 93:7. Reactions were performed in triplicate 
and error bars are the standard deviations.  
 
HPLC analysis of the reactions between 1 and 5a showed that different active site mutants 
of TfNCS gave different diastereoisomeric ratios of the products. A ratio of 90:10 was observed 
for wild-type NCS lysate, lower than with purified NCS (94:6), most likely due to the increased 
background phosphate reaction when using lysate. The two most promising active site mutants 
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observed were L76V and M97V, where product diastereoisomeric ratios of 97:3 were 
observed. To fully explore the change in reaction selectivity of these two mutants, both mutant 
enzymes (M97V and L76V) were purified and reactions performed between 1 and 2a, 3a, 5a 
and phenylacetaldehyde (11a). The mutant M97F was also explored to provide a comparison 
with the M97V mutant (Figure 2).  
 
Figure 2: Yields and e.e.s of reactions of products of enzymatic reactions using purified 
TfNCS active site mutants. Reaction conditions: Dopamine.HCl (10 mM), aldehyde (20 mM), 
sodium ascorbate (5 mM), purified TfNCS (0.2 mg mL-1) in HEPES buffer (100 mM, pH 7.5) 
with DMSO (10% v/v) at 37 oC for 18 h; Yields were determined by product formation against 
standards using HPLC (SI Section 9.2). Reactions were performed on a 250 µL scale for 2b, 
5b and 11b. bReactions were performed on a 1 mL scale for 3b. E.e.s were determined by chiral 
analytical HPLC for 2b and 11b. Diastereoisomeric ratios were determined by 1H-NMR 
spectroscopy for 3b. The diastereoisomeric ratio was determined by analytical HPLC for 5b.   
 
Aldehyde 11a was used as a substrate with all three mutants to help determine whether the 
variants were affecting the stereochemistry of the product at the C-1 position. As previously 
reported, the reaction with wild-type TfNCS gave a high enantiomeric excess in the product 
11b,19 as did all the NCS variants tested here, implying that there was no effect on the 
stereochemistry at the C-1 position. For all reactions with 2a as the aldehyde substrate, a high 
enantiomeric excess (> 95%) in the product 2b was also retained. The enantiopurity of 2b also 
demonstrated that the variants were not affecting the stereochemistry at the C-1 position of the 
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products with a-methyl aldehydes as substrates. Yields with M97F and L76V and 2a as the 
aldehyde substrate were however slightly decreased compared to the wild-type.  
Most notably, for all 3 a-methyl aldehydes tested as substrates, the products of reactions 
with D29TfNCSL76V showed the same or improved stereoselectivities compared with the 
wild-type enzyme. There was a lowering in d.r. for all products in M97F reactions with the 
chiral a-methyl aldehydes, suggesting that this mutant is affecting the stereochemistry of the 
C-1’ position. With the bulky, chiral aldehyde 5a however, the diastereoisomeric ratio of the 
product 5b was improved compared with the wild-type for both M97V and L76V mutants, and 
both mutants gave the product in almost quantitative yields. For both mutants, there was also 
little change in diastereoisomeric ratio between using purified enzyme here compared with 
enzymatic lysate (Figure 1), highlighting that purified enzyme is not essential for gaining a 
high d.r. in the product in these reactions.  
 
Co-crystallised structure with an a-methyl reaction intermediate analogue. To 
rationalise the acceptance of a-methyl aldehydes by NCS, a crystal structure of 𝛥33TfNCS 
with a non-productive mimic of a reaction intermediate bound in the active site was obtained. 
This was based upon previously published work in our group, wherein the ‘dopamine-first’ 
mechanism of TfNCS was confirmed via a co-crystallised structure of 𝛥33TfNCS with a non-
productive mimic of the reaction.9 A non-productive, secondary amine mimic (R)-12 of the 
iminium ion intermediate of the reaction between 1 and (R)-5a was synthesised using an 
analogous method to the previously reported co-crystallised mimic, starting with 3,4-
bis(benzoyloxy)dopamine followed by amide coupling, reduction to give the amine and 
subsequent deprotection to give the mimic in 14% yield. The enantiopurity of the mimic was 
confirmed by chiral HPLC (method 2, SI Section 9.3) as >99% e.e., using a racemic standard 
12, synthesised in an analogous manner. A single enantiomer mimic (R)-12 (Scheme 4) was 
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used as the (R)-enantiomer of a-methyl aldehydes was preferentially accepted as substrates by 
the NCS as described above. The ‘aldehyde-part’ of the mimic was chosen to be (R)-5a as the 
phenyl group would provide extra electron density and aid identification of the ligand in the 
active site. Indeed, initial attempts to co-crystallise an unproductive mimic of the reaction 
between dopamine and racemic 3a resulted in multiple conformations of the mimic in the active 
site, so the ligand could not be clearly built into the density. 
 
Scheme 4: Design of mimic (R)-12 of the reaction between 1 and 5a, for co-crystallisation 
based upon the ligand previously co-crystallised with 𝛥33TfNCS (PDB: 5NON).  
 
A co-crystallised structure of 𝛥33TfNCS with mimic (R)-12 in the active site was gained at 
1.81 Å with a single copy in the asymmetric unit (PDB entry: 6RP3, Table S1). Compared to 
the previous apo structure of 𝛥33TfNCS (PDB: 5N8Q), the overall fold of NCS was retained 
(RMSD Ca = 0.587). The only notable difference in active side residue conformations was with 
Glu110 and Met97. The mimic density in the active site was less convincing than with the 
previously co-crystallised structure (PDB: 5NON) suggesting partial occupancy and other, 
minor multiple conformations of the ligand. A Polder34 map of the ligand density showed 
similar density features, with some uncertainty in the placement of the dopamine ring. 
However, the ‘aldehyde-end’ of the mimic could be observed relatively clearly and so this was 
used to help understand why these substrates are accepted and why activity varies with single-
point mutants.  
In this structure (Figure 3) the ligand is placed with both hydroxyl groups of the catechol 












iminium ion intermediate iminium ion mimic (R)-12
This work:
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configuration, likely reflecting a pre-cyclisation conformation. Previous studies involving the 
active site mutagenesis of key residues in NCS have shown that Lys122 is essential for catalytic 
activity.7,8 The hydrogen bonding distances are further away than in 5NON and the mimic 
appears to be further buried into the active site. A hydrogen bonding interaction can also be 
observed between the secondary amine of the mimic and Glu110, which is in a rare 
conformation, observed in only 1% of glutamic acid residues in the PDB, whereas in the 
previous structure, the amine was bound to both Glu110 and Asp141. This interaction is 
consistent with the ‘dopamine-first’ mechanism (detailed in SI Section 4) and we are likely 
observing another ‘snapshot’ of the mechanistic process. Phe112 is present in two different 
conformations in the novel structure (defined at 1:1 occupancy), as in the first holo structure 
of TfNCS (PDB: 2VQ5)7. In subunit B of 2VQ5, the phenylalanine conformation is uncommon, 
being present in only 1% of phenylalanine residues in the PDB. In structure 5NON, Phe112 is 
predominately in the conformation predicted by MD simulations and in subunit A of 2VQ5.8 
It is not known whether this unusual phenylalanine conformation is relevant to the NCS 
mechanism, perhaps suggesting an inhibitory mode with the residue acting as a ‘gatekeeper’, 
or if it is simply a crystallographic artefact. 
 
Figure 3: a) Location of mimic (R)-12 in the active site. Dotted lines show key distances or 
hydrogen-bonding interactions. Associated numbers are distances given in Å. b) Electron 
density of (R)-12 in the active site at contour level 0.81 RMSD.  
 
The density of the ‘dopamine-end’ of the mimic was less clear so the ligand was built in with 
both hydroxyl groups hydrogen-bonded to Lys122, reflecting a likely mixture between the two 
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potential conformations, productive and inhibitory. The phenyl group of the ‘aldehyde-end’ of 
the mimic sits close to Leu76. Mutation of this residue to valine resulted in improved 
stereoselectivity for NCS reactions with a-methyl aldehydes. The ‘aldehyde-end’ of the mimic 
can be observed clearly and the methyl group of the mimic appears to sit close to Met97, 
forcing the residue into a previously unseen conformation for this residue in NCS structures. 
Reducing bulk at this position by mutation to a valine residue, lowers d.r.s for the reaction with 
aldehyde 3a, thus providing extra space for an ethyl group and so both enantiomers of the 
aldehyde are more readily able to react with dopamine in the active site. However, this does 
not provide enough extra space for the phenyl group of 5a and so one enantiomer is accepted 
preferentially. An increased d.r. in the product 5b compared to the wild-type is likely due to 
improved binding of the aldehyde from this extra space provided and also leads to increased 
reaction yields. Conversely, the mutant M97F reduced yield and d.r.s in all products, likely due 
to lack of space in this region of the active site.  The mutant L76V improved d.r.s with both 
chiral aldehydes, likely altering the shape of the active site cavity so that binding of the (R)-
enantiomer is preferential.  
Molecular dynamics simulations and mechanistic insights. With the aim of further 
understanding the preference for the (R)-enantiomer of the a-methyl aldehydes used, molecular 
dynamics simulations were performed. Four different starting structures with dopamine and 2-
phenylpropanal bound in different positions were defined, using chain A of PDB:5NON with 
the ligand removed (Figure 4). In starting structures A and B, 1 was placed inside the active 
site, and the (R)- and (S)-enantiomers of 5a (structures A and B, respectively) were placed at 
the active site entrance. In starting structures C and D, the two 5a enantiomers were placed 
inside the active site ((R)- and (S)-enantiomer, respectively), and 1 at the active site entrance. 
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Figure 4: Four different starting structures of substrates 1 and 5a bound to NCS. NCS is shown 
in as a cartoon and surface representation, allowing for identification of the active site binding 
pocket located as a void volume, approximately above Tyr108 and Asp141, delimited by 
Lys122 (right) and Tyr108 (left). Oxygen, nitrogen and hydrogen atoms are colored in red, 
blue and white, respectively. NCS is colored in grey and different colors of the bound substrates 
indicate the different starting structures. Dopamine was placed inside the active site, and the 
(R)- and (S)-enantiomers of 5a (A and B, respectively) were placed at the protein surface close 
to the active site entrance. The aldehyde 5a enantiomer was placed inside the active site ((R)- 
and (S)-enantiomer, respectively), and dopamine at the protein surface at the active site 
entrance (C and D, respectively). In all subsequent figures, the colors red, blue, magenta and 
green are used to indicate simulations starting from structures A, B, C and D, respectively. 
 
 Out of the 60 simulations launched, 58 completed successfully and two simulations with 
starting structure B aborted during minimisation, resulting in a total of 18.45 μs simulation 
time. Analyses of near attack complexes (NACs, conformers with dNAC < 4.0 Å, see SI Section 
6 for details) are summarised in Figure 5. Selected atoms of the two substrates were used for 
the calculation of dNAC (see SI Equation 1 for details). The 1858 conformers considered to be 
near attack complexes amount to 0.04% of all conformers, illustrating that the productive 
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binding of substrates is a very rare event. Starting structure A (1 inside the active site and (R)-
5a at the protein surface) yielded most NACs with dNAC < 4.0 Å (1745 conformers). Starting 
structures with dNAC < 4.0 Å, B and C, only yielded 90 and 23 conformers, respectively. Starting 
structure D did not result in any conformers with dNAC < 4.0 Å. The number of NACs with dNAC 
4.0 Å – 4.5 Å are also shown for illustrative purposes and a similar ratio of conformers across 
the starting structures was observed.  
 
Figure 5: Near attack conformation distances below 4.5 Å for the four different starting 
conformations A, B, C and D (Figure 4). The number of frames with NACs between 4.0 and 
4.5 Å is shown for illustration purposes.  
Based on analysis of all NACs with dNAC < 4.0 Å (Figure 5), it is possible to conclude that 
the (R)-enantiomer of 5a is preferred over the (S)-enantiomer with a ratio 95:5 conformers 
(1745:90 conformers), resulting  in the preferred production of the (1S,1’R)-product (5b). This 
preference agrees with the experimentally observed selectivity of NCS. Diastereoisomeric 
ratios (d.r.s) for these substrates were 94:6 (Scheme 2), between the (1S,1’R) and the (1S,1’S) 
products when racemic aldehyde was used. NACA therefore is most likely the NAC leading to 
the formation of the (1S,1’R)-product. The catalytic activity of NCS with 5a and dopamine is 
rather low indicated by the need for high substrate loading (10 mM), which is in agreement 
 20 
with our observation in molecular dynamics simulations, that productive substrate binding is a 
rare event, as only 0.04% of conformers show a NAC with dNAC < 4.0 Å.  
Visual analysis of the NACs led to the choice of representative conformers with dNAC < 4.0 
Å (Figure 6). Inspection of the substrate orientations in the active site showed that substrates 
showed consistent binding orientations in conformers originating from starting structure A with 
dNAC < 4.0 Å (Figure 6a, NACA). Two different, distinct binding orientations were visible for 
conformers originating from starting structure B with dNAC < 4.0 Å (Figures 6b and c, NACB1, 
NACB2). Another binding orientation was found for conformers originating from starting 
structure C with dNAC < 4.0 Å (Figure 6d, NACC). Examination of the NACs showed that in 
NACA, dopamine was oriented with the amine towards the amine of Lys122, with the hydroxy 
groups pointing further into the active site pocket, consistent with the dopamine first 
mechanism. (R)-5a was located closer to Tyr108, with its phenyl ring oriented towards Tyr108 
and its aldehyde group pointing towards the amine group of dopamine. Aldehyde (R)-5a was 
therefore located closer to the exit of the active site. For an illustration, see the movie 
(NACA.avi) in the SI. From analysis of the NACs with (R)- and (S)-5a, NACA was considered 
to be the most likely the NAC leading to the formation of the (1S,1’R)-product, so inspection 
of representative conformers for the other NACs will be considered briefly. NACB1 was similar 
to NACA: (S)-5a was located closer to Tyr108, with its phenyl ring oriented towards Tyr108. 
Dopamine was located close to Ly122. In NACB2, dopamine was located below and slightly to 
the left of (S)-5a. The amine of dopamine pointed away from Tyr108 and the two hydroxyl 
groups pointed towards Asp141. In NACC, 1 was located close to Tyr108, with its amine group 
oriented towards the hydroxyl group of Tyr108. All molecules were allowed to move freely, 
so it was possible that both substrates unbind from NCS and interact only with each other and 
the solvent. This was only observed in 9 conformers with dNAC < 4.0 Å. Root mean square 
function (RMSF) data showed a trend towards slightly higher RMSF values for simulations 
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with starting structures A and B (Figure S6). This trend was stronger when only considering 
NAC with dNAC < 4.0 Å (Figure S7). It is unclear whether this slightly increased flexibility 
impacts the mechanism of NCS. 
 
 
Figure 6: Figures a-d) are representative near attack complexes (NACA, NACB1, NACB2 and 
NACC) of simulations with starting structures A, B and C. Black, thick lines indicate the 
distances between atoms used to calculate dNAC. Figure e) shows the iminium ion mimic from 
PDB 6RP3 from the same viewpoint as the representative NACs. Figure f) shows NACA 
aligned with the iminium ion mimic from PDB 6RP3. Note that Figure e shows parts of a 
crystal structure, thus missing hydrogen atoms, and that Figure f shows the crystal structure (in 
white) aligned with NACA, which contains hydrogen atoms that were added for the simulations. 
 
Two conflicting mechanisms have been proposed for aldehyde activation and loss of water 
to allow formation of the iminium ion intermediate.8,9 Briefly, in the ‘aldehyde first’ 
mechanism, aldehyde activation is proposed to involve Lys122, with Tyr108 having a role in 
catechol deprotonation. However, since experimentally, bulky aldehyde substrates are 
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converted to THIQs, subsequent in silico modelling and a crystal structure with an imine 
intermediate analogue led to the proposed ‘dopamine first’ mechanism.8,9 In this mechanism, 
Glu110 is suggested to play the major role (together with Asp141 and Tyr108) in aldehyde 
activation and imine formation, with Lys122 deprotonating the catechol. 
In the reaction between 1 and (R)-5a, starting structure A where dopamine is positioned 
inside the active site leads to the most NACs (NACA). This indicates that the reaction is much 
more likely to happen if dopamine is bound to NCS first, followed by the aldehyde. Distances 
in NACA between substrate and the proposed catalytic residues were measured as an indicator 
for catalytic activity (Figure 7).   
 
Figure 7: Distances of the aldehyde functional group to key catalytic residues in the most 
prevalent near attack complexes, originating from starting structure A, NACA. Distance from 
the carbon of the aldehyde functional group to the a) nitrogen on Lys122, b) phenolic oxygen 
of Tyr108, c) oxygen of Glu110. d) Distances from the dopamine catechol oxygens to the 
nitrogen of Lys122.  
 
 
For NACA the distances between the substrate aldehyde carbon and Lys122 nitrogen and 
Tyr108 phenolic oxygen were 4.9 Å and 9.4 Å, respectively (Figure 7a,b). In addition, the 
distance between the substrate aldehyde carbon and Glu110 was 7.4 Å (Figure 7c). Assuming 
the dopamine first mechanism, this suggests that upon aminol formation, a movement of the 
substrate aldehyde towards Glu110 is required to facilitate the loss of water.8 The orientation 
of the meta-hydroxyl group of dopamine is crucial for NCS activity,7 which is supported by 
the observed distances between the hydroxyl groups of dopamine to the Lys122 nitrogen (4.7 
Å and 4.3 Å, for meta and para hydroxyl groups respectively, Figure 7d). Distances of the 
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dopamine amine to Asp141 and Glu110 were too far to allow hydrogen bonding (10.1 and 9.8 
Å, respectively, data not shown). Assuming the dopamine first mechanism, this suggests that 
upon aminol formation, a movement of the substrate dopamine towards Glu110 is required to 
facilitate the imine formation and cyclization. Indeed, the previous NMR study highlighted 
structural changes upon substrate complexation.6 The relative orientation of the substrates to 
each other in NACA is identical to the iminium ion mimic in the crystal structure, although the 
position of the substrates is slightly shifted (Figures 6e,f). The observed differences could 
indicate that upon formation of the aminol or the iminium ion intermediates, a slightly different 
binding interaction in the active site arises, compared to the individual substrates. In NACB1, 
NACB2 and NACC the orientation and position of substrates is different to the crystal structure. 
Molecular dynamics simulations were performed in a workflow, allowing repeatable 
simulation of the different starting structures in 15 replicates, as described in more detail in the 
methods section. We would like to highlight the fact that due to our workflow, we were able 
to conveniently perform and analyse in total 60 molecular simulations (4 starting structures, 5 
replicates of 100 ns each and 10 replicates of 400 ns each). Extensive sampling by long 
simulations and multiple replicates is crucial for obtaining sufficient sampling of rare events 
like productive binding of substrates to the active site.  Overall, the simulations were useful to 
rationalise the enantioselectivity observed and indicate initial positioning of the substrates in 
the active site. 
In summary, this work shows that a-methyl substituted aldehydes are accepted as substrates 
by wild-type TfNCS using both dopamine and a variety of analogues as the amine substrate. 
Products were generated in high yields (up to 97%) with high enantiomeric excess (>99%), or 
diastereoisomeric ratios (up to 94:6) with chiral a-methyl substituted aldehydes, providing a 
sustainable, facile route to these compounds. For chiral a-methyl substituted aldehydes the 
THIQ products were generated with two defined chiral centres, with (1S,1’R)-stereochemistry 
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as determined by the synthesis of two enantiomeric aldehydes. Active site mutants were 
capable of improving the diastereoisomeric ratios in the products (up to 98:2) with chiral a-
methyl substituted aldehydes and improved the reaction yields with several aldehydes. The 
enzymatic reaction was confirmed to occur via a mechanism that involves dopamine binding 
first to the active site, from a co-crystallized structure of D33TfNCS with a reaction 
intermediate mimic in the active site. Molecular dynamics simulations were performed to 
investigate the binding of dopamine and the (R)- and (S)-enantiomers of 2-phenylpropanal, into 
the NCS active site. The simulations provided supporting data that a kinetic resolution of the 
a-methyl substituted aldehyde was occurring and that the (R)-enantiomer of aldehyde was 
accepted preferentially.  
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